Translational Cell Therapy Lab News
-
Dr. Mitra Lavasani Earns Prestigious R01 Grant from NIH
Shirley Ryan AbilityLab’s Mitra Lavasani, PhD, the director of the Translational Cell Therapy Lab, will advance a novel approach that could help find if there a way to turn back the clock on aging.
In the News
-
Video: The Future of Osteoarthritis
Osteoarthritis (OA) is the one of the most common causes of debility and loss of function in the United States. Presented by Prakash Jayabalan, MD, PhD & Mitra Lavasani, PhD, the goal of this research team is to optimize the non-operative treatment of individuals with knee osteoarthritis to avoid or delay the need for total joint replacement.
In the News
-
Meet Mitra Lavasani, PhD
Meet Mitra Lavasani, PhD, Principal Investigator for the Translational Cell Therapy Lab at Shirley Ryan AbilityLab
In the News
